Sick Building Syndrome (SBS) is a collection of symptoms — headaches, dizziness, nausea, eye irritation, respiratory discomfort, and cognitive impairment — that building occupants experience in association with time spent in a particular building. While multiple factors contribute to SBS, paint and coating emissions represent a significant and preventable source that has been systematically underestimated.

The 2025 Ruzickova chamber study provided definitive evidence of the connection. In a 75 m³ test chamber with water-based polyurethane coatings applied to 80 m² of surface, researchers identified 96 organic compounds with potentially toxic properties — several of which have been associated with Sick Building Syndrome symptoms.

Sick Building Syndrome and Paint Emissions: The Indoor Air Quality Connection

The SBS-Coating Emission Link

The total VOC concentration at days 14–21 was 389.33 ± 30.96 µg/m³, with a TVOC of 180.61 ± 60.6 µg/m³. While the TVOC value fell within "excellent" air quality guidelines, the specific toxicological profile told a different story.

Specific SBS-Associated Compounds

The following coating-emitted compounds are directly linked to SBS symptoms in peer-reviewed literature:

The Dual-Phase Emission Pattern

Coating emissions follow a characteristic two-phase pattern that explains both acute and chronic SBS symptoms:

Phase 1: Acute Irritation (Days 0–14)

Highly volatile compounds — aromatic hydrocarbons, alcohols, ketones — dominate emissions in the first days and weeks. These compounds produce the immediate SBS symptoms that occupants notice: headaches, eye irritation, dizziness, and nausea. This phase accounts for more than 60% of total VOC reduction between days 14–21 and day 60.

Phase 2: Chronic Exposure (Days 14–60+)

Less volatile but toxicologically relevant compounds persist: aldehydes, ketones, low-volatility esters, and phthalates. These sustain chronic health effects including respiratory sensitization, neurotoxicity, and carcinogenic risk. Esters and phthalates show gradual decrease due to sorption on surfaces or within the coating matrix.

The Manufacturer Claims Gap

A critical finding of the Ruzickova study was that detectable VOC and SVOC emissions persisted beyond manufacturer-declared emission-free periods. Products marketed as having "zero emissions" after 14 days continued emitting 96 toxicologically relevant compounds at day 60.

This gap between marketing claims and actual emission behavior has serious implications for building occupancy decisions. Facilities that rely on manufacturer guidance for ventilation periods and occupancy timing may expose occupants to biologically active concentrations of hazardous compounds.

WHO Estimates: The Global Burden

The World Health Organization estimates 3.8 million annual deaths attributable to indoor air pollution, including VOC contributions from building materials. While this figure encompasses all indoor pollution sources, architectural coatings represent a significant and modifiable contributor.

For government buildings housing vulnerable populations, the implications are particularly concerning:

• Children exhibit higher ventilation rates relative to body mass and greater susceptibility to neurotoxic effects
• Elderly individuals may have diminished metabolic capacity for VOC elimination
• Immunocompromised individuals show enhanced responses to respiratory irritants
• Pregnant women face risks to fetal development from multiple coating constituents

The Ventilation Paradox

Standard remediation advice for SBS emphasizes ventilation. But ventilation has fundamental limitations for coating emissions:

1. Cold climates: Opening windows is impractical in winter
2. Urban environments: Outdoor air may contain additional pollutants
3. Persistent compounds: Low-volatility compounds are not efficiently removed by ventilation
4. Sorption/desorption: Compounds absorbed into furnishings and materials re-emit over time

Clausen's 1991 study found that reducing paint film thickness is more effective at reducing long-term emissions than reducing initial VOC content or increasing ventilation.

NIOSH Findings on Mixture Effects

The National Institute for Occupational Safety and Health has documented that exposure to coating-related VOCs at concentrations below individual compound permissible exposure limits can produce SBS symptoms through mixture interactions. The complex mixture of volatile compounds released from architectural coatings can interact synergistically to produce effects not predicted by individual compound toxicity.

Prevention: Source Elimination

The most effective SBS prevention strategy is source elimination. Powder coating systems, with their 100% solids formulation and zero VOC content, eliminate the emission source entirely. For government facilities where occupant health and productivity are priorities, specifying powder-coated architectural elements represents a direct intervention to prevent SBS and protect public health.

The evidence is clear: the headaches, fatigue, and respiratory symptoms that plague occupants of newly coated buildings are not imaginary. They are the predictable physiological response to a complex mixture of neurotoxic, carcinogenic, and irritant compounds — compounds that powder coating systems simply do not contain.